PRO Medicus Limited
PMCUF
$200.91
$3.911.99%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.91% | 29.51% | 29.02% | 28.46% | 25.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.91% | 29.51% | 29.02% | 28.46% | 25.95% |
| Cost of Revenue | 1.42% | -20.22% | -35.37% | -40.93% | -46.15% |
| Gross Profit | 29.96% | 29.63% | 29.21% | 28.71% | 26.26% |
| SG&A Expenses | 19.98% | 18.20% | 16.22% | 19.43% | 21.30% |
| Depreciation & Amortization | -16.27% | -15.41% | -14.62% | -4.68% | 4.56% |
| Other Operating Expenses | -48.46% | -31.98% | -18.99% | -13.34% | -8.62% |
| Total Operating Expenses | 11.84% | 10.50% | 9.01% | 13.20% | 16.21% |
| Operating Income | 37.71% | 38.17% | 38.68% | 35.85% | 30.67% |
| Income Before Tax | 38.02% | 39.50% | 41.19% | 37.71% | 31.77% |
| Income Tax Expenses | 40.47% | 42.12% | 43.97% | 37.74% | 28.87% |
| Earnings from Continuing Operations | 37.03% | 38.43% | 40.06% | 37.70% | 32.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.03% | 38.43% | 40.06% | 37.70% | 32.99% |
| EBIT | 37.71% | 38.17% | 38.68% | 35.85% | 30.67% |
| EBITDA | 37.67% | 38.09% | 38.55% | 35.71% | 30.54% |
| EPS Basic | 37.00% | 38.40% | 40.03% | 37.64% | 32.89% |
| Normalized Basic EPS | 37.98% | 39.90% | 42.05% | 38.11% | 31.70% |
| EPS Diluted | 37.05% | 38.42% | 39.99% | 37.60% | 32.84% |
| Normalized Diluted EPS | 37.98% | 39.92% | 42.09% | 38.15% | 31.70% |
| Average Basic Shares Outstanding | 0.03% | 0.03% | 0.02% | 0.03% | 0.03% |
| Average Diluted Shares Outstanding | 0.01% | 0.02% | 0.02% | 0.04% | 0.06% |
| Dividend Per Share | 35.48% | 34.54% | 33.38% | 32.70% | 29.84% |
| Payout Ratio | -0.03% | -0.04% | -0.05% | -0.02% | 0.03% |